This is further to our letter dated 16th November, 2018 in respect of the meeting with Analyst/Institutional Investor. Discussion in the above Meeting was about Company's history, growth over the years, category wise loan, Rights issue, object of issue, capital adequacy, composite of top management, past quarterly financial result, Director's Report 2018, Nasik expansion, products, etc. which are already available on Company's website.